In 1971 the United States declared war on cancer. Although there have been some improvements in treatments and screening the actual death rates for many cancers has not significantly been impacted. Considering the amount of money that has been spent and the amount of years that has passed since we declared war, we have not [...]
Both prostate cancer patients and their spouses benefit from family intervention counseling, but surprisingly spouses benefit more then the patients, this according to an article published in the December issue of Cancer! Learning about the diagnosis and then the treatment itself often has very negative effects on both the patient and the spouse. Knowing and [...]
According to a recent presentation by Mitchell C. Benson, MD*, at the 32nd Winter Urologic Forum - State-of-the-Art in Urology - January 25-29, 2008 - Vail, Colorado, USA most men who have failed a local, primary therapy and then experience a rising PSA will find that their follow-up therapy will most probably consist of anti-androgen [...]
Increasingly, we are using androgen deprivation therapy (ADT) either alone or in combination with radiation therapy for the treatment of localized, high-risk, or the biochemical relapse of prostate cancer (recurrent pc). Many studies have clearly demonstrated that bone mineral density (BMD) loss is rapid, especially during the first year of ADT. As much as 4.6% [...]
The normal protocol when chemotherapy is administered to men who have androgen-independent prostate cancer (AIPC) is to continue the androgen deprivation program despite its failure to any longer suppress the cancer’s growth. A study published by the Department of Medical Oncology, St Bartholomew's Hospital, London, UK, examined whether it was possible to re-induce hormone sensitivity [...]